Greenfield Savings Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Greenfield Savings Bank’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-379	Closed	-$240K	–	151
2025 Q1	$240K	Sell	379 -112	-23%	-$77K	0.12%	134
2024 Q4	$350K	Sell	491 -121	-20%	-$102K	0.17%	117
2024 Q3	$643K	Buy	612 +136	+29%	+$151K	0.31%	89
2024 Q2	$500K	Buy	476 +61	+15%	+$59.1K	0.26%	93
2024 Q1	$399K	Buy	415 +123	+42%	+$117K	0.21%	107
2023 Q4	$256K	Buy	292 +10	+4%	+$8.23K	0.15%	122
2023 Q3	$232K	Hold	282	–	–	0.15%	128
2023 Q2	$203K	Hold	282	–	–	0.14%	134
2023 Q1	$232K	Sell	282 -25	-8%	-$18.9K	0.15%	124
2022 Q4	$221K	Hold	307	–	–	0.15%	124
2022 Q3	$211K	Buy	+307	New	+$193K	0.15%	129

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Greenfield Savings Bank's REGN Position: Q2 2025 in Review

Greenfield Savings Bank sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 379 shares — an estimated $240K sold.

Greenfield Savings Bank first reported a position in REGN in Q3 2022 and held it in 11 quarters. The position peaked at $643K in Q3 2024. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

Greenfield Savings Bank reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Greenfield Savings Bank sold 379 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $240K.
Greenfield Savings Bank first reported a position in Regeneron Pharmaceuticals in Q3 2022 and held it in 11 quarters.
Greenfield Savings Bank's Regeneron Pharmaceuticals position peaked at $643K in Q3 2024.
1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Greenfield Savings Bank's 13F filing for Q2 2025, filed 7 Jul 2025.